PAVmed Inc (STU:1P50)
€ 2.78999 0 (0%) Market Cap: 10.40 Mil Enterprise Value: 36.24 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q4 2023 PAVmed Inc Earnings Call Transcript

Mar 27, 2024 / 12:30PM GMT
Release Date Price: €2.79
Operator

Good morning, and welcome to PAVmed's fourth quarter and full year 2023 business update conference call. At this time, all lines are in listen-only mode. (Operator Instructions) This call is being recorded on Wednesday, March 27, 2024. I would now like turn the conference over to Dennis McGrath, PAVmed President and Chief Financial Officer. Please go ahead, Dennis.

Dennis McGrath
PAVmed Inc. - CFO, President

Thank you, operator. Go morning, everyone, and thank you for participating in today's fourth quarter 2023 business update call. Press release announcing our business update for the company and financial results for the fourth quarter and full year ended December 31, 2023, is available on the PAVmed website. Please take a moment to read the disclaimer about forward-looking statements. The business update press release and this conference call both include forward looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot